Status:
COMPLETED
VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations
Lead Sponsor:
Rennes University Hospital
Conditions:
IVF
Endometriosis
Eligibility:
All Genders
18+ years
Brief Summary
The five proteins of the ITI (Inter-α-trypsin inhibitor) family, are essential components of the extracellular matrix, the dynamics of which they participate in the processes of cellular differentiati...
Detailed Description
Pilot study, prospective, single-center, biomedical
Eligibility Criteria
Inclusion
- For patients
- Patients having any of the following criteria:
- Patients with embryo transfer fresh or frozen
- Patients from an IVF cycle,
- Patients supported surgically for endometriosis Age between 18 and 45 years, Subjects affiliated to the social security Having given free and informed consent in writing.
- For donors
- Aged between 18 and 45 years,
- Subjects affiliated to the social security
- Having given free and informed consent in writing.
Exclusion
- For patients
- For all patients:
- Subjects under 18 years (minors)
- The majors protected (judicial protection, guardianship and curatorship) and persons deprived of their liberty,
- Patients with cancer of gynaecological origin or not,
- Patients with acute or chronic liver disease.
- For patients with embryo transfer:
- \- Patients with endometriosis.
- For patients with endometriosis:
- \- Hormonal treatment for endometriosis in progress.
- For donors
- For all donors:
- Subjects under 18 years (minors)
- The majors protected (judicial protection, guardianship and curatorship) and persons deprived of their liberty,
- Patients with cancer of gynaecological origin or not,
- Patients with acute or chronic liver disease.
- For female subjects:
- Taking hormonal contraception whatever the pharmaceutical or any other œstro-progestative treatment,
- Past or present support in Medically Assisted Reproduction,
- Subjects with an ongoing pregnancy,
- Subjects with endometriosis
- Menopausal subjects.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT01826500
Start Date
January 1 2013
End Date
January 1 2017
Last Update
January 18 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
EFS de Bretagne
Rennes, Britanny, France, 35000
2
Rennes University Hospital - Hôpital Sud
Rennes, Britanny, France, 35000